MUFG Securities Americas’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
2,376
+166
+8% +$93.1K 0.06% 252
2026
Q1
$1.24M Buy
2,210
+59
+3% +$37.8K 0.08% 226
2025
Q4
$1.46M Sell
2,151
-7
-0.3% -$4.77K 0.09% 196
2025
Q3
$1.38M Buy
2,158
+376
+21% +$228K 0.09% 203
2025
Q2
$956K Buy
1,782
+332
+23% +$159K 0.08% 221
2025
Q1
$609K Buy
1,450
+241
+20% +$105K 0.07% 248
2024
Q4
$500K Buy
+1,209
New +$530K 0.06% 262

Other funds holding IDXX

MUFG Securities Americas's IDXX Position: Q2 2026 in Review

MUFG Securities Americas increased its Idexx Laboratories (IDXX) stake by 7.5% in Q2 2026, buying an estimated $93.1K and bringing the position to 2,376 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #252.

MUFG Securities Americas first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.46M in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • MUFG Securities Americas held 2,376 shares of Idexx Laboratories worth $1.25M as of Q2 2026.
  • MUFG Securities Americas bought 166 Idexx Laboratories shares in Q2 2026, an estimated $93.1K.
  • Idexx Laboratories made up 0.06% of MUFG Securities Americas's portfolio in Q2 2026, its #252 holding.
  • MUFG Securities Americas first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • MUFG Securities Americas's Idexx Laboratories position peaked at $1.46M in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.